141 related articles for article (PubMed ID: 3163260)
1. 5q- syndrome terminating in acute myeloid leukemia. Karyotype evolution and immunologic characterization of blast cells.
Donti E; Tabilio A; Donti GV; Mecucci C; Carotti A; Grignani F; Martelli MF
Cancer Genet Cytogenet; 1988 Jun; 32(2):205-9. PubMed ID: 3163260
[TBL] [Abstract][Full Text] [Related]
2. A unique clone involving multiple structural chromosome rearrangements in a myelodysplastic syndrome case.
Yan J; Whittom R; Delage R; Drouin R
Cancer Genet Cytogenet; 2003 Jan; 140(2):138-44. PubMed ID: 12645652
[TBL] [Abstract][Full Text] [Related]
3. Blastic transformation associated with 5q- and 12p-.
Silva ML; Valente AN; Tabak D; Dobbin J; Souza JM; Abdelhay E; Pereira MS
Cancer Genet Cytogenet; 1990 Jul; 47(2):275-6. PubMed ID: 2357702
[No Abstract] [Full Text] [Related]
4. [5q anomaly in myelodysplasia and acute myelocytic leukemia].
Robak T
Acta Haematol Pol; 1990; 21(2):235-42. PubMed ID: 2151871
[No Abstract] [Full Text] [Related]
5. Molecular analysis of the 5q- chromosome.
Nagarajan L
Leuk Lymphoma; 1995 May; 17(5-6):361-6. PubMed ID: 7549826
[TBL] [Abstract][Full Text] [Related]
6. Ph-positive chronic myelogenous leukemia with a 5q-chromosome abnormality terminating in erythroblastic crisis.
Maekawa T; Misawa S; Taniwaki M; Takino T; Sonoda Y; Abe T
Cancer Genet Cytogenet; 1988 Sep; 34(2):261-3. PubMed ID: 3165699
[No Abstract] [Full Text] [Related]
7. 5q- anomaly preceding acute myeloblastic leukemia with 53 chromosomes without chromosome 5 abnormality.
Jonveaux P; Daniel MT; Berger R
Cancer Genet Cytogenet; 1993 Oct; 70(2):146-7. PubMed ID: 8242598
[TBL] [Abstract][Full Text] [Related]
8. Leukemic transformation in patients with 5Q- and additional abnormalities.
Larripa I; Acevedo S; Palau Nagore MV; Bengiò R; Mondini N; Slavutsky I
Haematologica; 1991; 76(5):363-7. PubMed ID: 1806438
[TBL] [Abstract][Full Text] [Related]
9. Idiopathic myelofibrosis in blast transformation with 4;12 and 5;12 translocations and a 7q deletion.
Przepiorka D; Bryant E; Kidd P
Cancer Genet Cytogenet; 1988 Jan; 30(1):139-44. PubMed ID: 3422039
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the 5q- breakpoint in an acute nonlymphocytic leukemia patient using pulsed-field gel electrophoresis.
Thornton DE; Theil K; Payson R; Balcerzak SP; Chiu IM
Am J Med Genet; 1991 Dec; 41(4):557-65. PubMed ID: 1723247
[TBL] [Abstract][Full Text] [Related]
11. Clinical and prognostic implications of chromosome 5q deletions: 96 high resolution studied patients.
Pedersen B; Jensen IM
Leukemia; 1991 Jul; 5(7):566-73. PubMed ID: 2072742
[TBL] [Abstract][Full Text] [Related]
12. Patients with del(5q) MDS who fail to achieve sustained erythroid or cytogenetic remission after treatment with lenalidomide have an increased risk for clonal evolution and AML progression.
Göhring G; Giagounidis A; Büsche G; Kreipe HH; Zimmermann M; Hellström-Lindberg E; Aul C; Schlegelberger B
Ann Hematol; 2010 Apr; 89(4):365-74. PubMed ID: 19855965
[TBL] [Abstract][Full Text] [Related]
13. Progression of essential thrombocythemia to blastic crisis via idiopathic myelofibrosis.
Emilia G; Sacchi S; Temperani P; Longo R; Vecchi A
Leuk Lymphoma; 1993 Mar; 9(4-5):423-6. PubMed ID: 8348078
[TBL] [Abstract][Full Text] [Related]
14. Two karyotypically unrelated clones with 5q- and 20q- in a primary myelodysplastic syndrome patient evolving into acute nonlymphocytic leukemia.
Hirokawa M; Miura I; Miura AB
Int J Hematol; 1995 Aug; 62(2):121-5. PubMed ID: 8590773
[TBL] [Abstract][Full Text] [Related]
15. Evolution of multiple cytogenetic clones and leukemic transformation in a case of myelodysplastic syndrome.
Donti E; Donti GV; Falzetti F; Rosetti A; Grignani F; Tabilio A
Med Oncol Tumor Pharmacother; 1989; 6(3):233-8. PubMed ID: 2615526
[TBL] [Abstract][Full Text] [Related]
16. Promyelocytic blast crisis of Philadelphia-positive thrombocythemia with translocations (9;22) and (15;17).
Laï JL; Fenaux P; Zandecki M; Savary JB; Estienne MH; Jouet JP; Bauters F; Deminatti M
Cancer Genet Cytogenet; 1987 Dec; 29(2):311-4. PubMed ID: 3479236
[TBL] [Abstract][Full Text] [Related]
17. 5q- and disordered haematopoiesis.
Bunn HF
Clin Haematol; 1986 Nov; 15(4):1023-35. PubMed ID: 3552346
[No Abstract] [Full Text] [Related]
18. Late appearing 5q--marker in refractory anemia.
Heim S; Billström R; Kristoffersson U; Mandahl N; Mitelman F
Cancer Genet Cytogenet; 1987 Jan; 24(1):159-62. PubMed ID: 3466668
[TBL] [Abstract][Full Text] [Related]
19. Concurrent acute myeloid leukemia with inv(16)(p13.1q22) and chronic lymphocytic leukemia: molecular evidence of two separate diseases.
Lu CM; Murata-Collins JL; Wang E; Siddiqi I; Lawrence H
Am J Hematol; 2006 Dec; 81(12):963-8. PubMed ID: 16917916
[TBL] [Abstract][Full Text] [Related]
20. Incidence of 17p deletions and TP53 mutation in myelodysplastic syndrome and acute myeloid leukemia with 5q deletion.
Sebaa A; Ades L; Baran-Marzack F; Mozziconacci MJ; Penther D; Dobbelstein S; Stamatoullas A; Récher C; Prebet T; Moulessehoul S; Fenaux P; Eclache V
Genes Chromosomes Cancer; 2012 Dec; 51(12):1086-92. PubMed ID: 22933333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
